Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-25-005502
Filing Date
2025-03-14
Accepted
2025-03-14 17:33:12
Documents
2
Period of Report
2025-03-13

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3949
2 B. CARTER POA exhibit24-1.txt EX-24.1 3256
  Complete submission text file 0001062993-25-005502.txt   8638
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Issuer) CIK: 0001177648 (see all company filings)

EIN.: 043205099 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ZYMOGENETICS, INC. 1201 EASTLAKE AVENUE SEATTLE WA 98102
Business Address
CARTER BRUCE L A (Reporting) CIK: 0001225503 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35839 | Film No.: 25741466